The DOI matches its Crossref record; 76 of the 76 references it cites were found in a registry or an index.
Methadone—metabolism, pharmacokinetics and interactions
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The P450 Superfamily: Update on New Sequences, Gene Mapping, and Recommended Nomenclature
NEBERT, D. W., NELSON, D. R., COON, M. J., ESTABROOK, R. W., FEYEREISEN, R., FUJII-KURIYAMA, Y., GONZALEZ, F. J., GUENGERICH, F. P., GUNSALUS, I. C., JOHNSON, E. F., et al. (1991) · DNA and Cell Biology · doi:10.1089/dna.1991.10.1 · Cited by 1,094
Inhibition and Induction of Cytochrome P450 and the Clinical Implications
Lin, J. H., & Lu, A. Y. H. (1998) · Clinical Pharmacokinetics · doi:10.2165/00003088-199835050-00003 · Cited by 829
Pharmacokinetic Interactions with Rifampicin: Clinical Relevance
Niemi, M., Backman, J. T., Fromm, M. F., Neuvonen, P. J., & Kivist??, K. T. (2003) · Clinical Pharmacokinetics · doi:10.2165/00003088-200342090-00003 · Cited by 764
Korzekwa, K. R., Krishnamachary, N., Shou, M., Ogai, A., Parise, R. A., Rettie, A. E., Gonzalez, F. J., & Tracy, T. S. (1998) · Biochemistry · doi:10.1021/bi9715627 · Cited by 511
Nakamura, K., Goto, F., Ray, W. A., McAllister, C. B., Jacqz, E., Wilkinson, G. R., & Branch, R. A. (1985) · Clinical Pharmacology and Therapeutics · doi:10.1038/clpt.1985.194 · Cited by 452
Shou, M., Grogan, J., Mancewicz, J. A., Krausz, K. W., Gonzalez, F. J., Gelboin, H. V., & Korzekwa, K. R. (1994) · Biochemistry · doi:10.1021/bi00187a009 · Cited by 351
Drug Interactions with Grapefruit Juice
Ameer, B., & Weintraub, R. A. (1997) · Clinical Pharmacokinetics · doi:10.2165/00003088-199733020-00003 · Cited by 348
Heroin Addiction—A Metabolic Disease
Dole, V. P. (1967) · Archives of Internal Medicine · doi:10.1001/archinte.120.1.19 · Cited by 347
Pharmacokinetics and pharmacodynamics of methadone in patients with chronic pain
Inturrisi, C. E., Colburn, W. A., Kaiko, R. F., Houde, R. W., & Foley, K. M. (1987) · Clinical Pharmacology and Therapeutics · doi:10.1038/clpt.1987.47 · Cited by 270
Barry, M., Gibbons, S., Back, D., & Mulcahy, F. (1997) · Clinical Pharmacokinetics · doi:10.2165/00003088-199732030-00003 · Cited by 254
Drug Interactions with Grapefruit Juice: Extent, Probable Mechanism and Clinical Relevance
Fuhr, U. (1998) · Drug Safety · doi:10.2165/00002018-199818040-00002 · Cited by 252
The mu1, mu2, delta, kappa opioid receptor binding profiles of methadone stereoisomers and morphine
Kristensen, K. (1995) · Life Sciences · doi:10.1016/0024-3205(94)00426-s · Cited by 234
Rifampin-Induced Methadone Withdrawal
Kreek, M. J., Garfield, J. W., Gutjahr, C. L., & Giusti, L. M. (1976) · New England Journal of Medicine · doi:10.1056/nejm197605132942008 · Cited by 215
Methadone in man: Pharmacokinetic and excretion studies in acute and chronic treatment
Verebely, K., Volavka, J., Mulé, S., & Resnick, R. (1975) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt1975182180 · Cited by 184
Pharmacologic Treatment of Heroin-Dependent Patients
O'Connor, P. G., & Fiellin, D. A. (2000) · Annals of Internal Medicine · doi:10.7326/0003-4819-133-1-200007040-00008 · Cited by 183
The Emerging Role of Cytochrome P450 3A in Psychopharmacology
Ketter, T. A., Flockhart, D. A., Post, R. M., Denicoff, K., Pazzaglia, P. J., Marangell, L. B., George, M. S., & Callahan, A. M. (1995) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199512000-00002 · Cited by 172
Garrido, M. J., & Trocóniz, I. F. (1999) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/s1056-8719(00)00043-5 · Cited by 160
The levels of methadone in the plasma in methadone maintenance
Inturrisi, C. E., & Verebely, K. (1972) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt1972135part1633 · Cited by 151
Altice, F. L., Friedland, G. H., & Cooney, E. L. (1999) · AIDS · doi:10.1097/00002030-199905280-00012 · Cited by 148
Disposition of methadone in man after a single oral dose
Inturrisi, C. E., & Verebely, K. (1972) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt1972136923 · Cited by 141
Moody, D. E., Alburges, M. E., Parker, R., Collins, J. M., & Strong, J. M. (1997) · PubMed · Cited by 131
Eap, C. B., Cuendet, C., & Baumann, P. (1990) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.1990.37 · Cited by 126
McCance‐Katz, E. F., Rainey, P. M., Friedland, G. H., & Jatlow, P. I. (2003) · Clinical Infectious Diseases · doi:10.1086/376907 · Cited by 125
Inhibition of methadone and buprenorphine N-dealkylations by three HIV-1 protease inhibitors.
Iribarne, C., Berthou, F., Carlhant, D., Dréano, Y., PICART, D., Dévéhat, F. L., & Riché, C. (1998) · PubMed · Cited by 123
Cytochrome P450 2D6 Genotype and Methadone Steady-State Concentrations
Eap, C. B., Broly, F., Mino, A., Hämmig, R., Déglon, J. J., Uehlinger, C., Meili, D., Chevalley, A.-F., Bertschy, G., ZULLINO, D. F., et al. (2001) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200104000-00016 · Cited by 114
Meresaar, U., Nilsson, M., Holmstrand, J., & �ngg�rd, E. (1981) · European Journal of Clinical Pharmacology · doi:10.1007/bf00542102 · Cited by 114
Phenytoin-Induced Methadone Withdrawal
Tong, T. G., Pond, S. M., KREEK, M. J., JAFFERY, N. F., & BENOWITZ, N. L. (1981) · Annals of Internal Medicine · doi:10.7326/0003-4819-94-3-349 · Cited by 113
Estimation of methadone clearance: application in the management of cancer pain
Plummer, J. L., Gourlay, G. K., Cherry, D. A., & Cousins, M. J. (1988) · Pain · doi:10.1016/0304-3959(88)90290-4 · Cited by 110
Methadone maintenance: Plasma levels and therapeutic outcome
Holmstrand, J., Änggård, E., & Gunne, L. (1978) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt1978232175 · Cited by 109
Clinical Pharmacokinetics of Methadone
Nilsson, M. I., Meresaar, U., & Änggård, E. (1982) · Acta Anaesthesiologica Scandinavica · doi:10.1111/j.1399-6576.1982.tb01850.x · Cited by 108
Methadone Plasma Level: Sustained by a Reservoir of Drug in Tissue
Dole, V. P., & Kreek, M. J. (1973) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.70.1.10 · Cited by 105
Clinical eftects and pharmacokinetics of racemic methadone and its optical isomers
Olsen, G. D., Wendel, H. A., Livermore, J. O., et al. (1977) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt1977212147 · Cited by 104
Clarke, S. M., Mulcahy, F. M., Tjia, J. F., et al. (2001) · Clinical Infectious Diseases · doi:10.1086/322519 · Cited by 102
Inhibition of human cytochrome P450 2D6 (CYP2D6) by methadone.
Wu, D., Otton, S. V., Sproule, B. A., et al. (1993) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1993.tb05666.x · Cited by 100
Methadone concentrations in plasma and their relationship to drug dosage
Wolff, K., Sanderson, M. J., Hay, A. W., et al. (1991) · Clinical Chemistry · doi:10.1093/clinchem/37.2.205 · Cited by 97
The biotransformation of methadone in man: Synthesis and identification of a major metabolite
Beckett, A. H., Taylor, J. F., CASY, A. F., & Hassan, M. M. A. (1968) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1968.tb09634.x · Cited by 96
Drug interactions of the newer oral antifungal agents
Katz (1999) · British Journal of Dermatology · doi:10.1046/j.1365-2133.1999.00011.x · Cited by 95
Disposition of methadone in methadone maintenance
Änggård, E., Gunne, L., Holmstrand, J., McMahon, R. E., Sandberg, C.-G., & Sullivan, H. R. (1975) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt1975173258 · Cited by 95
HIV and harm reduction for injection drug users
Brettle, R. P. (1991) · AIDS · doi:10.1097/00002030-199102000-00001 · Cited by 94
Pharmacokinetics of methadone and its primary metabolite in 20 opiate addicts
de Vos, J. W., Ufkes, J. G. R., Wilgenburg, H. V., Geerlings, P. J., & van den Brink, W. (1995) · European Journal of Clinical Pharmacology · doi:10.1007/bf00194951 · Cited by 91
Begré, S., von Bardeleben, U., Ladewig, D., et al. (2002) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200204000-00017 · Cited by 90
Effect of urinary pH on the disposition of methadone in man
Nilsson, M., Widerl�v, E., Meresaar, U., et al. (1982) · European Journal of Clinical Pharmacology · doi:10.1007/bf00548403 · Cited by 88
Horns, W. H., Radó, M., & Goldstein, A. (1975) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt1975176636 · Cited by 81
Steady-state pharmacokinetics of methadone in opioid addicts
Wolff, K., Hay, A. W. M., Raistrick, D., & Calvert, R. T. (1993) · European Journal of Clinical Pharmacology · doi:10.1007/bf00315479 · Cited by 80
Eap, C. B., Bertschy, G., Powell, K., et al. (1997) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199704000-00010 · Cited by 80
Methadone binding to human plasma proteins
Olsen, G. D. (1973) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt1973143338 · Cited by 79
Drug Abuse and Addiction Treatment Research
Leshner, A. I. (1997) · Archives of General Psychiatry · doi:10.1001/archpsyc.1997.01830200015002 · Cited by 78
Gerber, J. G., Rosenkranz, S. L., Segal, Y., Aberg, J. A., D'Amico, R. D., Mildvan, D., Gulick, R. M., Hughes, V., Flexner, C. W., Aweeka, F. T., et al. (2001) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/00126334-200106010-00010 · Cited by 73
Mj, K. (1973) · PubMed · Cited by 72
Interaction of Methadone with Didanosine and Stavudine
Rainey, P. M., Friedland, G. H., McCance‐Katz, E. F., Andrews, L., Mitchell, S. M., Charles, C., & Jatlow, P. L. (2000) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/00126334-200007010-00008 · Cited by 71
Interactions between methadone and medications used to treat HIV infection: a review.
Gourevitch, M. N., & FRIEDLAND, G. H. (2000) · PubMed · Cited by 70
Diazepam and methadone interactions in methadone maintenance
Preston, K. L., Griffiths, R. R., Stitzer, M. L., Bigelow, G. E., & Liebson, I. A. (1984) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.1984.215 · Cited by 70
Modified Directly Observed Therapy (MDOT) for Injection Drug Users with HIV Disease
McCance‐Katz, E. F., Gourevitch, M. N., Arnsten, J. H., Sarlo, J. A., Rainey, P. M., & Jatlow, P. L. (2002) · American Journal on Addictions · doi:10.1080/10550490290088072 · Cited by 70
Nilsson, M., �ngg�rd, E., Holmstrand, J., & Gunne, L. M. (1982) · European Journal of Clinical Pharmacology · doi:10.1007/bf00548404 · Cited by 69
Methadone maintenance: Effect of urinary pH on renal clearance in chronic high and low doses
Bellward, G. D., Warren, P., Howald, W. N., et al. (1977) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt197722192 · Cited by 67
Decreased Methadone Effect after Ritonavir Initiation
Geletko, S. M., & Erickson, A. D. (2000) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.20.1.93.34654 · Cited by 65
In vitro interactions between fluoxetine or fluvoxamine and methadone or buprenorphine
Iribarne, C., PICART, D., Dréano, Y., & Berthou, F. (1998) · Fundamental and Clinical Pharmacology · doi:10.1111/j.1472-8206.1998.tb00941.x · Cited by 59
Methadone Blood Concentrations Are Decreased by the Administration of Abacavir Plus Amprenavir
Bart, P., Rizzardi, P. G., Gallant, S., et al. (2001) · Therapeutic Drug Monitoring · doi:10.1097/00007691-200110000-00010 · Cited by 59
Clinical and toxicological consequences of the inductive potential of ethanol
Klotz, U. E., & Ammon, E. (1998) · European Journal of Clinical Pharmacology · doi:10.1007/s002280050412 · Cited by 59
Effect of Opioid Dependence Pharmacotherapies on Zidovudine Disposition
McCance‐Katz, E. F., Rainey, P. M., Friedland, G. H., Kosten, T. R., & Jatlow, P. L. (2001) · American Journal on Addictions · doi:10.1111/j.1521-0391.2001.tb00519.x · Cited by 56
METABOLIC INTERACTIONS BETWEEN OPIATES AND ALCOHOL *
Kreek, M. J. (1981) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1981.tb12789.x · Cited by 56
Methadone Patients and Alcohol Abuse
Ottomanelli, G. A. (1999) · Journal of Substance Abuse Treatment · doi:10.1016/s0740-5472(98)00030-0 · Cited by 50
Interactions Between Antipsychotic and Antihypertensive Drugs
Markowitz, J. S., Wells, B. G., & Carson, W. H. (1995) · Annals of Pharmacotherapy · doi:10.1177/106002809502900610 · Cited by 49
Effect of buprenorphine on CYP3A activity in rat and human liver microsomes
Ibrahim, R. B., Wilson, J. G., Thorsby, M. E., & Edwards, D. J. (2000) · Life Sciences · doi:10.1016/s0024-3205(00)00436-7 · Cited by 46
Tarumi, Y., Pereira, J., & Watanabe, S. (2002) · Journal of Pain and Symptom Management · doi:10.1016/s0885-3924(01)00368-2 · Cited by 46
The Effect of Dexamethasone on the Pharmacokinetics of Triazolam
Villikka, K., Kivistö, K. T., & Neuvonen, P. J. (1998) · Pharmacology & Toxicology · doi:10.1111/j.1600-0773.1998.tb01457.x · Cited by 45
Therapeutic drug monitoring of methadone in HIV-infected patients receiving protease inhibitors.
Beauverie, P., Taburet, A., Dessalles, M. C., Furlan, & Touzeau, D. (1998) · PubMed · Cited by 42
Nilsson, M. I., Gr�nbladh, L., Widerl�v, E., & �ngg�rd, E. (1983) · European Journal of Clinical Pharmacology · doi:10.1007/bf00542117 · Cited by 39
Garrido, M. J., Aguirre, C., Trocóniz, I. F., et al. (2000) · International Journal of Clinical Pharmacology and Therapeutics · doi:10.5414/cpp38035 · Cited by 38
Lack of Methadone Dose Alterations or Withdrawal Symptoms During Therapy With Lopinavir/Ritonavir
Stevens, R. C., Rapaport, S., Maroldo-Connelly, L., Patterson, J. B., & Bertz, R. (2003) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/00126334-200308150-00016 · Cited by 28
Methadone Maintenance Therapy for Opioid Dependence
Ward, J., Bell, J. R., Mattick, R. P., & Hall, W. (1996) · CNS Drugs · doi:10.2165/00023210-199606060-00004 · Cited by 25
Garrido, M. J., Jiminez, R., Gomez, E., et al. (1996) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1996.tb05917.x · Cited by 24
Loimer, N., Schmid, R. W., Grünberger, J., Jagsch, R., Linzmayer, L., & Presslich, O. (1991) · Psychopharmacology · doi:10.1007/bf02244255 · Cited by 24
[Drug interactions with antiretroviral agents].
Furlan, V., & Taburet, A. M. (2001) · PubMed · Cited by 17
Erythromycin: drug interactions.
Gurevitz, S. L. (1997) · PubMed · Cited by 13
Borg, L., & Kreek, M. J. (1995) · Current Opinion in Psychiatry · doi:10.1097/00001504-199505000-00014 · Cited by 12
Cited by
Pharmacotherapy in the Treatment of Addiction: Methadone
Kreek, M. J., Borg, L., Ducat, E., & Ray, B. (2010) · Journal of Addictive Diseases · doi:10.1080/10550881003684798 · Cited by 108
Goldner, E. M., Lusted, A., Roerecke, M., Rehm, J., & Fischer, B. (2014) · Addictive Behaviors · doi:10.1016/j.addbeh.2013.11.022 · Cited by 102
Alexander, K., Kronk, R., Sekula, K., Short, V., & Abatemarco, D. (2019) · Issues in Mental Health Nursing · doi:10.1080/01612840.2019.1585499 · Cited by 15
Metadata
- Authors
- FERRARI, A., COCCIA, C., BERTOLINI, A., & STERNIERI, E.
- Venue
- Pharmacological Research
- Publisher
- Elsevier BV
- Published
- 2004-12
- Volume
- 50
- Issue
- 6
- Pages
- 551-559
- ISSN
- 1043-6618 (ISSN-L)
- OpenAlex
- W2021011301
- Cited by
- 384
- References
- 76
- FWCI
- 8.91
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.